A Tale of Two Markets: Why the Future Looks Different for Hogs and Cattle
By Emily Balsamo
Loading...

These fundamentals, however, influence hog and cattle markets differently. Exports comprise a greater share of domestic pork production than in beef, making pork (and thus hog) markets typically more sensitive to international politics and trade flow disruption. The figure below shows the export share of domestic production of pork vs. beef and veal annually over the past decade. From 2012 to 2022, between 20% and 26% of pork produced in the United States was exported, compared to only 9% to 12% of beef and veal.

Dependence on international markets makes livestock prices sensitive to a variety of factors; disease, for example, when present in one market can quickly send ripples globally. African Swine Fever (ASF), which has been present in international hog markets, has caused noteworthy trade disruption in recent years. A significant share of U.S. domestic pork is exported to China where phytosanitary policy and national demand can change quickly. These factors underlie the Lean Hog complex’s higher volatility relative to the Live Cattle complex, as seen in the figure below.

The Year to Come

The market appears to be expecting tightening supplies of beef in the coming year due to falling domestic production and lower carcass weights. Pork production and supplies, conversely, are expected to rise in 2023, year-over-year, according to the USDA. Exports for pork, which comprise a greater share of domestic production than for beef and veal, are also expected to fall in 2023 over 2022. Differing fundamental factors will continue to contribute to independent forward curves, export profiles, and historical volatility among Lean Hog and Live Cattle markets into next year.

Loading...

About the author

Emily Balsamo
Emily Balsamo

is a Manager of Commodity Research and Product Development. She is based in Chicago.

 

 

OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.

All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).

©2025 CME Group Inc. All rights reserved